Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings-Reference-Cited by-同舟云学术

Optimization of a Low Cost and Broadly Sensitive Genotyping Assay for HIV-1 Drug Resistance Surveillance and Monitoring in Resource-Limited Settings

Published:2011-11-23 Issue:11 Volume:6 Page:e28184
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhou Zhiyong,Wagar Nick,DeVos Joshua R.,Rottinghaus Erin,Diallo Karidia,Nguyen Duc B.,Bassey Orji,Ugbena Richard,Wadonda-Kabondo Nellie,McConnell Michelle S.,Zulu Isaac,Chilima Benson,Nkengasong John,Yang Chunfu

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference52 articles.

1. Epidemiology of antiretroviral drug resistance in drug-naive persons.;AM Geretti;Curr Opin Infect Dis,2007

2. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.;DE Bennett;Curr Opin Infect Dis,2006

3. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.;S Bertagnolio;Antivir Ther,2008

4. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.;MR Jordan;Antivir Ther,2008

5. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.;DE Bennett;PLoS One,2008

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological and molecular assessment of HIV-1 mutations for antiretroviral drug resistance in Saudi Arabia;PLOS ONE;2024-06-26

2. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan;Viruses;2024-06-14

3. Prevalence, predictors and geospatial patterns of HIV drug resistance in South Africa: Insights from the 2017 national HIV household survey;2024-05-28

4. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program;Viruses;2023-12-23

5. Need assessment for HIV drug resistance testing and landscape of current and future technologies in low- and middle-income countries;PLOS Global Public Health;2023-10-18